Strengths
Evitria has a specialized focus on recombinant antibody expression in CHO cells, allowing for unmatched expertise in this niche market.
The company boasts a fast turnaround time of just 4 weeks from sequence to antibody, which is a significant advantage in the biotechnology sector.
With over 99% of projects completed on time, Evitria demonstrates high reliability and commitment to customer satisfaction.
The low levels of endotoxin (<1 EU/mg) in their products enhance the quality and safety of the antibodies produced.
Evitria's single-service focus leads to higher quality and efficiency compared to competitors who offer a broader range of services.
The company has established a strong reputation as a trusted partner in the biotechnology sector, enhancing its brand positioning.
High customer satisfaction ratings indicate strong service reliability, with clients often praising the speed and quality of service.
Evitria's global presence, with offices in Zurich, San Diego, Boston, London, and Singapore, allows for effective service delivery across multiple regions.